| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Activity and Immune Correlates of Programmed Death-1 Blockade Therapy in Patients With Advanced Large Cell Neuroendocrine Carcinoma
|
Shirasawa, Masayuki
|
|
|
22 |
4 |
p. 282-291.e6
|
article
|
| 2 |
A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non–small-cell Lung Cancer: SWOG 1206 (8811)
|
Argiris, Athanassios
|
|
|
22 |
4 |
p. 313-323.e1
|
article
|
| 3 |
A Phase II Study to Assess the Efficacy of Osimertinib in Patients With EGFR Mutation-positive NSCLC Who Developed Isolated CNS Progression (T790M-negative or Unknown) During First- or Second-generation EGFR-TKI or Systemic Disease Progression (T790M-negative) After Treatment With First- or Second-generation EGFR-TKI and Platinum-based Chemotherapy (WJOG12819L)
|
Takeda, Masayuki
|
|
|
22 |
4 |
p. 376-380
|
article
|
| 4 |
A Prospective Trial Evaluating the Safety and Systemic Response From the Concurrent Use of Radiation Therapy with Checkpoint Inhibitor Immunotherapy in Metastatic Non–Small Cell Lung Cancer
|
Mattes, Malcolm D.
|
|
|
22 |
4 |
p. 268-273
|
article
|
| 5 |
Association of Immune-Related Adverse Events and Efficacy Outcomes With Consolidation Pembrolizumab After Chemoradiation in Patients With Inoperable Stage III Non–Small-Cell Lung Cancer
|
Shukla, Nikhil Atul
|
|
|
22 |
4 |
p. 274-281
|
article
|
| 6 |
Brown-Séquard Syndrome in a Desmoplastic Malignant Mesothelioma Patient: A Rare Complication
|
Ralki, Mike
|
|
|
22 |
4 |
p. e552-e554
|
article
|
| 7 |
Characteristics and Outcomes of Lung Cancer Screening Among Individuals With or Without Cancer History
|
Maller, Bradley
|
|
|
22 |
4 |
p. e629-e636
|
article
|
| 8 |
Clinician Variation in Ordering and Completion of Low-Dose Computed Tomography for Lung Cancer Screening in a Safety-Net Medical System
|
Gerber, David E.
|
|
|
22 |
4 |
p. e612-e620
|
article
|
| 9 |
Decreased Overall Survival in HIV-associated Non–small-cell Lung Cancer
|
Hysell, Kristen
|
|
|
22 |
4 |
p. e498-e505
|
article
|
| 10 |
Deep and Durable Response to Nivolumab and Temozolomide in Small-Cell Lung Cancer Associated With an Early Decrease in Myeloid-Derived Suppressor Cells
|
Owen, Dwight H.
|
|
|
22 |
4 |
p. e487-e497
|
article
|
| 11 |
Deterioration in Health-Related Quality of Life Diminishes Benefit of Lung Cancer Resection in Older Adults
|
Blakely, Andrew M.
|
|
|
22 |
4 |
p. e544-e551
|
article
|
| 12 |
Editorial Board
|
|
|
|
22 |
4 |
p. A1
|
article
|
| 13 |
Extended Sleeve Lobectomy is an Alternative for Centrally Located Lung Cancer With Superior Short- and Long-term Outcomes
|
Wang, Xing
|
|
|
22 |
4 |
p. e621-e628
|
article
|
| 14 |
Factors Affecting Long-Term Survival in Locally Advanced NSCLC Patients With Pathologic Complete Response After Induction Therapy Followed by Surgical Resection
|
Sassorossi, Carolina
|
|
|
22 |
4 |
p. e542-e543
|
article
|
| 15 |
Feasibility of Performing Transvascular Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration
|
Naaman, Rami
|
|
|
22 |
4 |
p. e595-e601
|
article
|
| 16 |
Intracranial Response of ALK + Non-Small-cell Lung Cancer to Second-line Dose-escalated Brigatinib After Alectinib Discontinuation Due to Drug-induced Hepatitis and Relapse After Whole Brain Radiotherapy Followed by Stereotactic Radiosurgery
|
Urbanska, Edyta Maria
|
|
|
22 |
4 |
p. e528-e532
|
article
|
| 17 |
Mesothelioma Micronodular Metastasis Pattern Confirmed by Transbronchial Cryobiopsy: Case Report
|
Kerkhoff, Jordy W.
|
|
|
22 |
4 |
p. e533-e535
|
article
|
| 18 |
MET Amplification (MET/CEP7 Ratio ≥ 1.8) Is an Independent Poor Prognostic Marker in Patients With Treatment-naive Non–Small-cell Lung Cancer
|
Yin, Wei
|
|
|
22 |
4 |
p. e512-e518
|
article
|
| 19 |
Ninety-Day Mortality: Redefining the Perioperative Period After Lung Resection
|
Taylor, Marcus
|
|
|
22 |
4 |
p. e642-e645
|
article
|
| 20 |
Nomograms for Predicting Overall and Recurrence-free Survival From Pathologic Stage IA and IB Lung Cancer After Lobectomy
|
Merritt, Robert E.
|
|
|
22 |
4 |
p. e574-e583
|
article
|
| 21 |
Nutritional Support in Lung Cancer Patients: The State of the Art
|
Mele, Maria Cristina
|
|
|
22 |
4 |
p. e584-e594
|
article
|
| 22 |
Osimertinib Maintenance After Definitive Chemoradiation in Patients With Unresectable EGFR Mutation Positive Stage III Non–small-cell Lung Cancer: LAURA Trial in Progress
|
Lu, Shun
|
|
|
22 |
4 |
p. 371-375
|
article
|
| 23 |
Patient-Reported Outcomes with Durvalumab With or Without Tremelimumab Versus Standard Chemotherapy as First-Line Treatment of Metastatic Non–Small-Cell Lung Cancer (MYSTIC)
|
Garon, Edward B.
|
|
|
22 |
4 |
p. 301-312.e8
|
article
|
| 24 |
Prognostic Significance of Lymph Node Count Removed at Sublobar Resection in Pathologic Stage IA Non–Small-cell Lung Cancer: A Population-Based Analysis
|
He, Zhicheng
|
|
|
22 |
4 |
p. e563-e573
|
article
|
| 25 |
Prognostic Value of KRAS Mutation Subtypes and PD-L1 Expression in Patients With Lung Adenocarcinoma
|
Tao, Luwei
|
|
|
22 |
4 |
p. e506-e511
|
article
|
| 26 |
Programmed Cell Death Ligand 1 Expression in Resected Non–Small Cell Lung Cancer
|
Yu, Hui
|
|
|
22 |
4 |
p. e555-e562
|
article
|
| 27 |
Prospective Validation of the Italian Alliance Against Cancer Lung Panel in Patients With Advanced Non–Small-Cell Lung Cancer
|
Gregorc, Vanesa
|
|
|
22 |
4 |
p. e637-e641
|
article
|
| 28 |
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non–small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors
|
Ferrara, Miriam Grazia
|
|
|
22 |
4 |
p. 351-360
|
article
|
| 29 |
Real World Characterization of Advanced Non–Small Cell Lung Cancer in Never Smokers by Actionable Mutation Status
|
Kerrigan, Kathleen
|
|
|
22 |
4 |
p. 260-267.e2
|
article
|
| 30 |
Safety and Efficacy of Stereotactic Body Radiotherapy in Ultracentral Lung Tumors Using a Risk-optimized Fractionation Scheme
|
Regnery, Sebastian
|
|
|
22 |
4 |
p. 332-340.e3
|
article
|
| 31 |
Second-line Afatinib or Chemotherapy Following Immunochemotherapy for the Treatment of Metastatic, Squamous Cell Carcinoma of the Lung: Real-world Effectiveness and Safety From a Multisite Retrospective Chart Review in the USA
|
Kim, Edward S.
|
|
|
22 |
4 |
p. 292-300.e1
|
article
|
| 32 |
Solid Components in the Mediastinal Window of Computed Tomography Define a Distinct Subtype of Subsolid Nodules in Clinical Stage I Lung Cancers
|
Yin, Jiacheng
|
|
|
22 |
4 |
p. 324-331
|
article
|
| 33 |
Subtypes of EGFR- and HER2-Mutant Metastatic NSCLC Influence Response to Immune Checkpoint Inhibitors
|
Lau, Sally C.M.
|
|
|
22 |
4 |
p. 253-259
|
article
|
| 34 |
Surgical Prognosis of Synchronous Multiple Primary Lung Cancer: Systematic Review and Meta-Analysis
|
Nie, Yuntao
|
|
|
22 |
4 |
p. 341-350.e3
|
article
|
| 35 |
Survival Trends of Metastatic Lung Cancer in California by Age at Diagnosis, Gender, Race/Ethnicity, and Histology, 1990-2014
|
Li, Tianhong
|
|
|
22 |
4 |
p. e602-e611
|
article
|
| 36 |
Table of Contents
|
|
|
|
22 |
4 |
p. A2-A4, A6-A9
|
article
|
| 37 |
Trabectedin in Malignant Pleural Mesothelioma: Results From the Multicentre, Single Arm, Phase II ATREUS Study
|
Cortinovis, Diego
|
|
|
22 |
4 |
p. 361-370.e3
|
article
|
| 38 |
Transformations First Into Squamous-Cell Carcinoma and Later Into Sarcomatoid Carcinoma After Acquired Resistance to Osimertinib in a Patient With EGFR-Mutant Lung Adenocarcinoma: Case Report
|
Lee, Po-Hsin
|
|
|
22 |
4 |
p. e536-e541
|
article
|
| 39 |
Treatment at Integrated Centers Might Bridge the Academic-Community Survival Gap in Patients With Metastatic Non-Small Cell Carcinoma of the Lung
|
Ramalingam, Sendhilnathan
|
|
|
22 |
4 |
p. e646-e653
|
article
|
| 40 |
Treatment of Non–Small-Cell Lung Cancer Based on Circulating Cell-Free DNA and Impact of Variation Allele Frequency
|
Bustamante Alvarez, Jean G.
|
|
|
22 |
4 |
p. e519-e527
|
article
|
Journal description